Clinical Trial Shows Remdesivir Quickened Recovery From COVID-19

A vial of the drug remdesivir is visually inspected at a Gilead manufacturing site in March 2020. Gilead Sciences via AP

A rigorous trial sponsored by the U.S. government showed remdesivir has a clear impact on hospitalization time for COVID-19 patients, Dr. Anthony Fauci said on Wednesday.

Fauci heads the National Institute of Allergy and Infectious Diseases (NIAID), which provided funding for the clinical trial.